Loading company details...
Beta
Latest Form 4 (Mar 23, 2026): Brian Baranick (EVP, GM, Precision Oncology): Grant/Award of 33,321 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 23, 2026 | Brian Baranick, EVP, GM, Precision Oncology | Grant/Award | 33,321 | n/a |
| Mar 23, 2026 | James Herriott, SVP, General Counsel & Sec | Disposition to Issuer | 68,195 | n/a |
| Mar 23, 2026 | Aaron Bloomer, EVP, Chief Financial Officer | Grant/Award | 89,911 | n/a |
| Mar 23, 2026 | Sarah Condella, EVP, Human Resources | Grant/Award | 60,389 | n/a |
| Mar 23, 2026 | Kevin T. Conroy, President and CEO | Grant/Award | 119,312 | n/a |
| Mar 23, 2026 | Jacob A. Orville, EVP, GM, Screening | Grant/Award | 53,323 | n/a |
| Mar 23, 2026 | D. Scott Coward | Disposition to Issuer | 52,164 | n/a |
| Mar 23, 2026 | Shacey Petrovic | Disposition to Issuer | 16,406 | n/a |
| Mar 23, 2026 | Katherine S. Zanotti | Disposition to Issuer | 55,361 | n/a |
| Mar 23, 2026 | Kimberly J. Popovits | Disposition to Issuer | 6,725 | n/a |